Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Cardiovascular Drug Reviews|July 9, 2003
Lipoprotein lipase activator NO-1886Weidong Yin, Kazuhiko TsutsumiMetabolism: Clinical and Experimental|December 12, 2003
Lipoprotein lipase activator NO-1886 (ibrolipim) accelerates the mRNA expression of fatty acid oxidation-related enzymes in rat liverMasako Doi, Yasunori Kondo, Kazuhiko TsutsumiBiological & Pharmaceutical Bulletin|October 24, 2002
The relationship between lipoprotein lipase activity and respiratory quotient of rats in circadian rhythmsKazuhiko Tsutsumi, Yasuhide Inoue, Yasunori KondoArzneimittel-Forschung|September 19, 2002
Effects of the lipoprotein lipase activator NO-1886 as a suppressor agent of atherosclerosis in aorta of mild diabetic rabbitsWeidong Yin, Kazuhiko Tsutsumi, Zhonghua Yuan, et al.Drug Research|July 3, 2018
Effects of Concomitant Administration of a Dipeptidyl Peptidase-4 Inhibitor in Japanese Patients with Type 2 Diabetes Showing Relatively Good Glycemic Control Under Treatment with a Sodium Glucose Co-Transporter 2 InhibitorMasataka Kusunoki, Yukie Natsume, Tetsuro Miyata, et al.Drug Research|July 3, 2018
Effects of Concomitant Administration of Sodium Glucose Co-transporter 2 Inhibitor with Insulin on Hemoglobin A1c, Body Mass Index and Serum Lipid Profile in Japanese Type 2 Diabetic PatientsMasataka Kusunoki, Yukie Natsume, Tetsuro Miyata, et al.Journal of Clinical Medicine Research|June 9, 2021
Influence of Luseogliflozin on Vaginal Bacterial and Fungal Populations in Japanese Patients With Type 2 DiabetesMasataka Kusunoki, Kazuhiko Tsutsumi, Naomi Wakazono, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|August 22, 2020
The Effects of Pemafibrate in Japanese Patients with Type 2 Diabetes Receiving HMG-CoA Reductase InhibitorsMasataka Kusunoki, Takahiko Sakazaki, Kazuhiko Tsutsumi, et al.Journal of Clinical Medicine Research|December 20, 2021
Effect of Treatment With Sodium-Glucose Cotransporter 2 Inhibitor on the Initiation of Continuous Positive Airway Pressure Therapy in Type 2 Diabetic Patients With Obstructive Sleep Apnea SyndromeMasataka Kusunoki, Fumiya Hisano, Naomi Wakazono, et al.Drug Research|March 13, 2020
Effects of Additional Administration of a Selective Inhibitor of Sodium Glucose co-transporter-2 Inhibitor on the Glycemic Control in Japanese Type 2 Diabetes Mellitus Patients Receiving Treatment with a Dipeptidyl Peptidase-4 InhibitorMasataka Kusunoki, Daisuke Sato, Takahiko Sakazaki, et al.Pageof 4